ENLV · Enlivex Ltd
United States · RS rating 1 · As of 2026-10-14
| Price | 0.22 USD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 1 / 1 / 2 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 5 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +98.8% |
| Market cap (USD) | $218.6M |